Antares Pharma, Inc. (ATRS)

Sales/Maturities of Investments

$996.00K

TTM · Period ending: · USD

ATRS logo

ATRS Sales/Maturities of Investments

Latest reported$996.00K
ATRS TTM Sales/Maturities of Investments ($4.65M → $996.00K)
High-resolution chart · PNG

ATRS sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
996,000
0
2,000,000
8,000,000
16,500,000
22,500,000
20,500,000
14,500,000
6,000,000
0
0
0
0
0
5,000,000
5,000,000
5,000,000
5,000,000
3,000,000
9,000,000
12,000,000
15,000,000
12,000,000
6,000,000
6,000,000
6,000,000
9,000,000
15,000,000
21,000,000
24,000,000
30,000,000
36,000,000
30,000,000
24,000,000
18,000,000
9,000,000
9,000,000
12,000,000
9,000,000
6,000,000
3,000,000
0
0
0
0
0
0
0
0
0
0
953,160
7,226,656
16,015,057
20,902,420
22,639,470
19,050,838
13,163,037
11,179,886
8,489,676
5,804,812
2,904,212
0
1,897,477
7,897,477
13,897,477
19,897,477
18,000,000
12,000,000
6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,343,400
3,843,400
4,443,400
6,443,400
6,148,666
7,248,666
6,648,666
4,648,666
1,600,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.